Evolve Private Wealth’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Evolve Private Wealth's BCAT Position: Q2 2026 in Review
Evolve Private Wealth reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 48% in Q2 2026, selling an estimated $737K and leaving 51,089 shares worth $814K. The position accounts for 0.05% of the portfolio, ranked #344.
Evolve Private Wealth first reported a position in BCAT in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.4M in Q4 2025. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- Evolve Private Wealth held 51,089 shares of BlackRock Capital Allocation Term Trust worth $814K as of Q2 2026.
- Evolve Private Wealth sold 47,980 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $737K.
- BlackRock Capital Allocation Term Trust made up 0.05% of Evolve Private Wealth's portfolio in Q2 2026, its #344 holding.
- Evolve Private Wealth first reported a position in BlackRock Capital Allocation Term Trust in Q4 2025 and has held it in 3 quarters since.
- Evolve Private Wealth's BlackRock Capital Allocation Term Trust position peaked at $1.4M in Q4 2025.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.